Success Stories

CPESN® Hawaii pharmacist Courtney Elam shares her network's success working in partnership with the Hawaii Department of Health and the National Kidney Foundation to provide COVID-19 Testing (1:40).

CPESN® North Carolina pharmacist Tori Grooms shares her network's success with a large MCO through conducting patient outreach to complete Medication Therapy Managament reviews for health plan identified Medicare patients.

CPESN® USA and Arkansas CPESN® board member Duane Jones shares his network's success providing patient identification and patient recruitment into clinical trials with RxE2 (5:00).

CPESN® New York Vice President Chris Daly shares his network's success being awarded a CDC 815 grant through the New York Department of Health to provide DSME services. All three CPESN NY networks are involved – Upstate NY, NYC, and Western New York, with 30 to 50 pharmacies participating at any time.
10 pharmacies are now accredited to hold their own diabetes classes and refer patients into those classes.

CPESN® West Virginia luminary Gretchen Garofoli describes that network's participation in Nalox(ONE) with grant funding through the West Virginia Drug Intervention Institute. Eight CPESN West Virginia pharmacies have opted into the program to counsel patients, provide disposal kits, and prescribe and dispense Naloxone based on risk screening. Pharmacies are reimbursed on a per patient encounter, and for follow-up patient calls made by pharmacy technicians

CPESN Hawaii® luminary Keri Oyadomari describes how pharmacies in that network provided In-home COVID-19 vaccines to more than ,000 small care homes, group homes, foster homes with 1 to 8 patients. The service was funded through a grant from the state department of health.

A multi-state agreement with Holston Medical Group gives CPESN pharmacists new patient insights with access to patient Electronic Medical Records (EMRs) and direct communication with physicians on services they provide to referred patients. CPESN Northeast Tennessee initiated the relationship with HMG which has a presence in TN, VA, NC, SC. Its Emergent ACO also has presence in NE and parts of CA. The program was first rolled out to CPESN pharmacies in NE Tennessee and SW Virginia.

Medication Therapy Management (MTM) services are provided by CPESN Minnesota pharmacies to both Medical Assistance (Medicaid) and MinneaCare patients taking at least one prescription medication to manage a chronic condition. Reviews are conducted face-to-face or via telehealth.

Dayna Wong-Otis describes a brief medication review program for the 65+ population funded by Hawaii Medical Services Association (HMSA). Pharmacists look for age-inappropriate medications, duplications, interactions, and findings reported to patient’s primary care physician with recommendations.

Dana Sadowski describes how a Colorado Department of Health grant has provided funding for CPESN Colorado pharmaies to become accredited and begin offering clinical services including Diabetes Self-Management Education (DSME) and blood pressure monitoring.

CPESN® Missouri and USA luminary Tripp Logan describes how he connected the dots on backyard relationships to build a grant-winning partnership in this video highlighting patience and persistence in making the community pharmacy case for quality health service delivery, improved patient care, and overall lower costs.

Joe Moose, CPESN North Carolina luminary, describes how pharmacists helped this large national MCO gather information from dually-eligible Medicare and Medicaid patients on their COVID-19 vaccination status, and understanding of their choices.

50 CPESN Arkansas pharmacies participate in this large MCO contract to provide an inital Medication Therapy Management session with referred patients.

Program for HTN is expanded in Year 3 to include cholesterol values and lipid levels for total cardiovascular risk management. The goal is through pharmacist-led intervention to lower the patient risk of heart attack or stroke.

In partnership with the South Dakota Dept. of Health, CPESN® pharmacists provided blood pressure monitoring, met with patients regularly, and led clinical interventions engaging other health professionals. The results? High percentage of patients met BP goals, and the program has expanded from the initial focus on HTN to include cholesterol values and lipid levels for total cardiovascular risk management.

Under a contract with a Medicaid MCO, 100 Pennyslvania Pharmacists Care Network - CPESN® Pennsylvania pharmacies engaged eligible patients to participate in Medication Synchronization services. The goal was to close HEDIS® identified gaps in care, using MedSync and documenting through eCare plans.

CPESN® Arkansas pilot program to improve medication adherence in behavioral health patients. Pharmacists provided counseling on adherence to behavioral health medications, and conversion to long-acting anti-psychotic injectables for some patients.

This program under a contract with a large national health plan called for completion of health risk assessments for plan identified patients. Pharmacists and their support staff completed the HRAs in person and by telephone.

A partnership beween CPESN Ohio and Ohio-based Mobility Health supported network pharmacies in providing PCR COVID-19 testing.

In its first statewide payer program with a Medicaid MCO, 53 of 58 CPESN Missisippi pharmacies had patients eligible for pharmacist-led intervientions for diabetes patients.

John Croce, CPESN Upstate New York Managing Network Facilitator, describes a six-month health screening program and survey of social determinants of health. Referrals are made to healthcare teams for needed services.

Josh Orhtman with South Dakota CPESN describes a pilot program for remote monitoring for Medicare beneficiaries. Patients heart failure, diabetes, hypertension receive blood pressure monitors, scales, diabetic testing supplies. Pharmacies and physician teams receive health status readings via cellular signals from the patients' in-home monitoring devices.

This multi-state contract with a Medicaid MCO covers Medicaid patients living in Ohio and Indiana. Network pharmacies provided Comprehensive Medical Reviews and targeted interventions.

Network pharmacists submit monthly care plans for this MCO's member taking Asthma, COPD, Opioids, or Behavioral Health medications.

CPESN NYC pharmacists work with Medicare Part D patients to increase adherence rates for statins, oral diabetic drugs, and HTN medications under this contract with a statewide health insurer.

Todd Brown describes how CPESN Massachusetts pharmacists work with a large community-based healthcare system to close identified gaps in care, provide medication sychronication, and adherence support to Medicaid dually-eligible and Medicare patients.

Renee Price describes a Medication Therapy Management program with a statewide managed Medicaid program where network pharmacies worked with care managers to improve patient health conditions. The program started with 5 to 10 pilot stores in Kansas, and added two to three pharmacies monthly.

Under renewal of this contract with a Medicare Advantage Plan, 58 CPESN Mississippi pharmacies provide diabetes monitoring and management including A1c testing to establish a base level, counseling to help patients with an A1c >9, bring it under 9%, and make referrals for annual retinal eye exams.

Under this Year 5 program renewal with a national payer, CPESN Wyoming pharmacies provide enhanced Medication Therapy Management and safety reviews for Medicare Part D patients at high risk for adverse drug events. The goal is to demonstrate a positive impact on medical spend directly tied to pharmacist interventions.

In this contract with a statewide Medicaid MCO, Pennsylvania Pharmacist Care Network pharmacists identify gaps in care and address medication adherence for plan-identified patients with COPD and diabetes.